Tyra Biosciences, Inc. Basic Shares Outstanding (Weighted Average)
Tyra Biosciences, Inc. (TYRA) reported Basic Shares Outstanding (Weighted Average) of 65.99 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 65.99M shares, a 10.81% increase year-over-year.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 61.75M shares, a 4.06% increase year-over-year.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 59.84M shares, a 1.29% increase year-over-year.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 59.67M shares, a 1.35% increase year-over-year.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 59.60M shares, a 4.17% increase from fiscal 2024.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 57.22M shares, a 33.98% increase from fiscal 2023.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 42.70M shares, a 1.96% increase from fiscal 2022.
- Tyra Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 41.88M shares, a 203.94% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 65.99M shares 10-Q · filed 2026-08-04 | 63.88M shares 10-Q · filed 2026-08-04 | 62.52M shares derived: average of 3 quarters · filed 2026-08-04 | 61.81M shares derived: average of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | 61.75M shares 10-Q · filed 2026-05-13 | 60.79M shares derived: average of 2 quarters · filed 2026-05-13 | 60.42M shares derived: average of 3 quarters · filed 2026-05-13 | 60.20M shares derived: average of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | 59.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 59.75M shares derived: average of 2 quarters · filed 2026-03-02 | 59.69M shares derived: average of 3 quarters · filed 2026-08-04 | 59.60M shares 10-K · filed 2026-03-02 | ||
| 2025-09-30 | 59.67M shares 10-Q · filed 2025-11-05 | 59.61M shares derived: average of 2 quarters · filed 2026-08-04 | 59.52M shares 10-Q · filed 2025-11-05 | 59.41M shares derived: average of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | 59.55M shares 10-Q · filed 2026-08-04 | 59.44M shares 10-Q · filed 2026-08-04 | 59.32M shares derived: average of 3 quarters · filed 2026-08-04 | 59.21M shares derived: average of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | 59.34M shares 10-Q · filed 2026-05-13 | 59.21M shares derived: average of 2 quarters · filed 2026-05-13 | 59.09M shares derived: average of 3 quarters · filed 2026-05-13 | 58.99M shares derived: average of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | 59.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 58.97M shares derived: average of 2 quarters · filed 2026-03-02 | 58.87M shares derived: average of 3 quarters · filed 2026-03-02 | 57.22M shares 10-K · filed 2026-03-02 | ||
| 2024-09-30 | 58.87M shares 10-Q · filed 2025-11-05 | 58.77M shares derived: average of 2 quarters · filed 2025-11-05 | 56.60M shares 10-Q · filed 2025-11-05 | 53.18M shares derived: average of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | 58.67M shares 10-Q · filed 2025-08-14 | 55.45M shares 10-Q · filed 2025-08-14 | 51.29M shares derived: average of 3 quarters · filed 2025-08-14 | 49.18M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 52.23M shares 10-Q · filed 2025-05-08 | 47.60M shares derived: average of 2 quarters · filed 2025-05-08 | 46.02M shares derived: average of 3 quarters · filed 2025-05-08 | 45.16M shares derived: average of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | 42.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 42.92M shares derived: average of 2 quarters · filed 2025-03-27 | 42.81M shares derived: average of 3 quarters · filed 2025-03-27 | 42.70M shares 10-K · filed 2025-03-27 | ||
| 2023-09-30 | 42.87M shares 10-Q · filed 2024-11-07 | 42.73M shares derived: average of 2 quarters · filed 2024-11-07 | 42.62M shares 10-Q · filed 2024-11-07 | 42.51M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 42.59M shares 10-Q · filed 2024-08-07 | 42.49M shares 10-Q · filed 2024-08-07 | 42.40M shares derived: average of 3 quarters · filed 2024-08-07 | 42.30M shares derived: average of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | 42.39M shares 10-Q · filed 2024-05-09 | 42.30M shares derived: average of 2 quarters · filed 2024-05-09 | 42.20M shares derived: average of 3 quarters · filed 2024-05-09 | 42.09M shares derived: average of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | 42.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 42.10M shares derived: average of 2 quarters · filed 2024-03-19 | 41.99M shares derived: average of 3 quarters · filed 2024-03-19 | 41.88M shares 10-K · filed 2024-03-19 | ||
| 2022-09-30 | 42.00M shares 10-Q · filed 2023-11-07 | 41.89M shares derived: average of 2 quarters · filed 2023-11-07 | 41.78M shares 10-Q · filed 2023-11-07 | 41.73M shares derived: average of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | 41.78M shares 10-Q · filed 2023-08-10 | 41.67M shares 10-Q · filed 2023-08-10 | 41.65M shares derived: average of 3 quarters · filed 2023-08-10 | 33.53M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 41.55M shares 10-Q · filed 2023-05-04 | 41.58M shares derived: average of 2 quarters · filed 2023-05-04 | 30.77M shares derived: average of 3 quarters · filed 2023-05-04 | 23.65M shares derived: average of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | 41.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 25.39M shares derived: average of 2 quarters · filed 2023-03-22 | 17.68M shares derived: average of 3 quarters · filed 2023-03-22 | 13.78M shares 10-K · filed 2023-03-22 | ||
| 2021-09-30 | 9.16M shares 10-Q · filed 2022-11-03 | 10.62M shares 10-Q · filed 2021-11-03 | 5.72M shares derived: average of 2 quarters · filed 2022-11-03 | 4.50M shares 10-Q · filed 2022-11-03 | 5.98M shares 10-Q · filed 2021-11-03 | |
| 2021-06-30 | 2.27M shares 10-Q · filed 2022-08-04 | 2.14M shares 10-Q · filed 2022-08-04 | ||||
| 2020-09-30 | 3.05M shares 10-Q · filed 2021-11-03 | 2.93M shares 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |